Development and characterization of ceftazidime-loaded niosomes against selected pathogens

Pharmaceutical Sciences Asia · Published 2025-01-01 · DOI 10.29090/psa.2025.04.25.3941

Authors being retrieved — see the publisher record. https://doi.org/10.29090/psa.2025.04.25.3941

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• The impact of supply-side and demand-side cost-containment strategies on universal health coverage outcomes in Southeast Asian National Health Insurance Schemes: A systematic review · Pharmaceutical Sciences Asia · 2025 · Same journal
• Comparative stability of imipenem and meropenem solutions for extended infusion administration · Pharmaceutical Sciences Asia · 2024 · Same journal
• Anxiolytic activity of black pepper (Piper nigrum L.) fruit extract: in vivo and in silico study · Pharmaceutical Sciences Asia · 2026 · Same journal
• Enhancing Cosmetic Formulations with Pleurotus cystidiosus Extract: A Study on Anti-Photoaging and Moisturizing Potential · Pharmaceutical Sciences Asia · 2024 · Same journal
• Cardioprotective Effect of Secretory Leukocyte Protease Inhibitor (SLPI) Partially Require Association with Cardiac Annexin A2 (AnxA2) · Pharmaceutical Sciences Asia · 2024 · Same journal
• Risk factors associated with metformin associated lactic acidosis (MALA) in type 2 diabetic patients receiving metformin · Pharmaceutical Sciences Asia · 2025 · Same journal
• Evaluation on therapeutic monitoring of vancomycin using the 2020 consensus guideline at one teaching hospital at Ho Chi Minh City · Pharmaceutical Sciences Asia · 2024 · Same journal
• Exploring antibiotic knowledge and dispensing behaviours in community pharmacy settings: a crosssectional study · Pharmaceutical Sciences Asia · 2025 · Same journal
• Development of Psoriasis-Like 3D Skin Models Using the HaCaT Keratinocyte Cell line as Potential Tools in Psoriasis Research · Pharmaceutical Sciences Asia · 2025 · Same journal
• Eugenol protects human liver HepG2 cells from H2O2-induced oxidative hepatotoxicity by maintaining ROS homeostasis, increasing IL-10 level, and upregulating CYP1B1 gene expression · Pharmaceutical Sciences Asia · 2024 · Same journal